Topline phase 3 results show that the novel nanobody gefurulimab is safe and effective for AChR-antibody-positive myasthenia gravis, but long-term results will be key.

The new approval allows patients to transition to a single 200mg subcutaneous injection once every 4 weeks, following completion of the induction phase.

Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on ...

For years, Texas patients seeking relief through the Texas medical cannabis program had only a few ways to take their ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

As local advocates work to create a syringe exchange program in Evansville, the framework for the whole system is up in the ...

IU football has its highest-ever national ranking following its week seven win at Oregon. The Hoosiers traveled to Autzen Stadium on Saturday afternoon and silenced the home crowd with a convincing 30 ...

During his court appearance, the influencer told the judges he had not considered the potential harm of his actions. (Image: X) A French social media influencer has been sentenced to six months in ...

A French influencer has been jailed for six months for faking syringe attacks on unsuspecting members of the public in a viral prank video. Ilan M., who goes by the online handle ‘Amine Mojito,’ was ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

A Houston man who was a former professor at Indiana University School of Medicine has been charged after he allegedly downloaded more than one million files of child sexual abuse material. What ...

Welcome to the IU Health Herald-Times Athlete of the Week poll for Sept. 1-6. Congratulations to last week's winner, Lighthouse Christian's Taylor Helbert, who received 54.3% of the votes (27,502) to ...